Sarepta Therapeutics ( NASDAQ: SRPT) reported a second fatality from acute liver failure in a patient treated with its gene ...

Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death ...

Roche discontinued the commercial and clinical use of Elevidys after two cases of fatal acute liver failure.

Sarepta Therapeutics said it has temporarily suspended shipments of Elevidys® (delandistrogene moxeparvovec-rokl) for infusion in non-ambulatory patients following the second death in three months of ...

Sarepta Therapeutics Inc. said a second patient has died of acute liver failure after being treated with its gene therapy for ...

The estimated cost that Belfast Trust has produced seems high and does not align with any other figures we have seen from ...

Retail investor chatter around Sarepta Therapeutics surged on Sunday after the company announced it had suspended shipments ...

Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...

Sarepta Therapeutics on Sunday said there had been a second reported case of acute liver failure resulting in death after a patient received the company's gene therapy for a rare form of muscular ...

After the completion of the 54th Italian-American Charity Golf Association Tournament on Saturday evening, it was time for ...

The Kansas City Chiefs have shared a super touching and heartfelt moment with a young Chiefs fan and Patrick Mahomes.